Zonal heterogeneity for gene expression in human pancreatic carcinoma - PubMed (original) (raw)
Zonal heterogeneity for gene expression in human pancreatic carcinoma
Toru Nakamura et al. Cancer Res. 2007.
Abstract
Using Affymetrix HG-U133 Plus 2.0 array and laser capture microdissection techniques, we determined whether different zones of the same pancreatic tumor exhibited differential expression of genes. Human L3.6pl pancreatic cancer cells were implanted into the pancreas of nude mice. Three weeks later when tumors were 7 to 9 mm in diameter, gene expression patterns in tumor cells within the central and peripheral zones were compared, and 1,222 genes showed statistically significant differences. Bioinformatic functional analysis revealed that 346 up-regulated genes in the peripheral zone were related to cytoskeleton organization and biogenesis, cell cycle, cell adhesion, cell motility, DNA replication, localization, integrin-mediated signaling pathway, development, morphogenesis, and IkappaB kinase/nuclear factor-kappaB cascade; 876 up-regulated genes in the central zone were related to regulation of cell proliferation, regulation of transcription, transmembrane receptor protein tyrosine kinase signaling pathways, response to stress, small GTPase-mediated signal transduction, hexose metabolism, cell death, response to external stimulus, carbohydrate metabolism, and response to wounding. The reliability of the microarray results were confirmed by in situ hybridization analysis of the expression of two genes. Collectively, the data showed zonal heterogeneity for gene expression profiles in tumors and suggest that characterization of zonal gene expression profiles is essential if microarray analyses of genetic profiles are to produce reproducible data, predict disease prognosis, and allow design of specific therapeutics.
Similar articles
- D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A, DelRaso NJ, Schlager JJ, Chan VT. Soto A, et al. Toxicology. 2008 Jan 14;243(1-2):177-92. doi: 10.1016/j.tox.2007.10.009. Epub 2007 Oct 23. Toxicology. 2008. PMID: 18061331 - Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment.
Nakamura T, Fidler IJ, Coombes KR. Nakamura T, et al. Cancer Res. 2007 Jan 1;67(1):139-48. doi: 10.1158/0008-5472.CAN-06-2563. Cancer Res. 2007. PMID: 17210693 - [Selection of genes related to multidrug resistance of pancreatic ductal adenocarcinoma by microarray analysis].
Feng B, Zhao YP, Chen G, Zhang TP, Wu YD. Feng B, et al. Zhonghua Wai Ke Za Zhi. 2007 Dec 1;45(23):1629-33. Zhonghua Wai Ke Za Zhi. 2007. PMID: 18453221 Chinese. - DNA array/microarrays in oncological research with focus on pancreatic cancer.
Baron A, Moore PS, Scarpa A. Baron A, et al. Adv Clin Path. 2001 Oct;5(4):115-20. Adv Clin Path. 2001. PMID: 17582935 Review. - Functional biology of the primate fetal adrenal gland: advances in technology provide new insight.
Coulter CL. Coulter CL. Clin Exp Pharmacol Physiol. 2004 Aug;31(8):475-84. doi: 10.1111/j.1440-1681.2004.04031.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15298538 Review.
Cited by
- Laser Capture Microdissection: A Gear for Pancreatic Cancer Research.
Rao BH, Souček P, Hlaváč V. Rao BH, et al. Int J Mol Sci. 2022 Nov 23;23(23):14566. doi: 10.3390/ijms232314566. Int J Mol Sci. 2022. PMID: 36498893 Free PMC article. Review. - Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma.
Liu X, Wang W, Liu X, Zhang Z, Yu L, Li R, Guo D, Cai W, Quan X, Wu H, Dai M, Liang Z. Liu X, et al. Clin Transl Med. 2022 Jan;12(1):e670. doi: 10.1002/ctm2.670. Clin Transl Med. 2022. PMID: 35061935 Free PMC article. - Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact.
Gutiérrez ML, Muñoz-Bellvís L, Orfao A. Gutiérrez ML, et al. Cancers (Basel). 2021 Sep 3;13(17):4451. doi: 10.3390/cancers13174451. Cancers (Basel). 2021. PMID: 34503261 Free PMC article. Review. - Unraveling Tumor Heterogeneity by Using DNA Barcoding Technologies to Develop Personalized Treatment Strategies in Advanced-Stage PDAC.
Dujardin P, Baginska AK, Urban S, Grüner BM. Dujardin P, et al. Cancers (Basel). 2021 Aug 20;13(16):4187. doi: 10.3390/cancers13164187. Cancers (Basel). 2021. PMID: 34439341 Free PMC article. Review. - Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
Botrus G, Kosirorek H, Sonbol MB, Kusne Y, Uson Junior PLS, Borad MJ, Ahn DH, Kasi PM, Drusbosky LM, Dada H, Surapaneni PK, Starr J, Ritter A, McMillan J, Wylie N, Mody K, Bekaii-Saab TS. Botrus G, et al. Oncologist. 2021 Jul;26(7):569-578. doi: 10.1002/onco.13717. Epub 2021 Mar 5. Oncologist. 2021. PMID: 33555095 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical